BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN
BEGIN:VTIMEZONE
TZID:Mountain Standard Time
BEGIN:STANDARD
DTSTART:20251102T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11
TZNAME:Mountain Standard Time
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:Mountain Daylight Time
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Developing CAR T cell Platforms for Precision Targeting of Diab
 etogenic T cells in&nbsp\;Mouse Models of T1DExplore innovative advances i
 n immunotherapy for type 1 diabetes (T1D) in this RIP seminar\, featuring 
 Dr. Prashanth Francis&mdash\;2024 CU DRC P&amp\;F awardee and Assistant Pr
 ofessor at CU Anschutz\, Gates Institute. Dr. Francis will present his awa
 rd-winning work on developing novel CAR T cell platforms for precise targe
 ting of diabetogenic T cells in mouse models of type 1 diabetes. His platf
 orm targets CD8 T cells via their T cell receptors and has shown promise i
 n preventing T1D in a polyclonal RIP-mOVA mouse model. Building on this su
 ccess\, he is expanding the approach to target both diabetogenic CD4 and C
 D8 T cells in NOD mice\, advancing specific immunotherapy for T1D. Please 
 join us!Speaker:Prashanth Francis\, MD PhD\, Assistant Professor\, Divisio
 n of Gastroenterology and Hepatology\, CU Anschutz\; Translational Researc
 h\, Gates Institute
DTEND:20251027T190000Z
DTSTAMP:20260417T061205Z
DTSTART:20251027T180000Z
LOCATION:
SEQUENCE:0
SUMMARY:Speaker: Prashanth Francis\, Division of Gastroenterology & Hepatol
 ogy
UID:RFCALITEM639120031254400311
X-ALT-DESC;FMTTYPE=text/html:<p><strong>Developing CAR T cell Platforms for
  Precision Targeting of Diabetogenic T cells in&nbsp\;Mouse Models of T1D<
 /strong><br /></p><p>Explore innovative advances in immunotherapy for type
  1 diabetes (T1D) in this RIP seminar\, featuring <strong>Dr. Prashanth Fr
 ancis</strong>&mdash\;2024 CU DRC P&amp\;F awardee and Assistant Professor
  at CU Anschutz\, Gates Institute. <br /></p><p>Dr. Francis will present h
 is award-winning work on developing novel CAR T cell platforms for precise
  targeting of diabetogenic T cells in mouse models of type 1 diabetes. His
  platform targets CD8 T cells via their T cell receptors and has shown pro
 mise in preventing T1D in a polyclonal RIP-mOVA mouse model. Building on t
 his success\, he is expanding the approach to target both diabetogenic CD4
  and CD8 T cells in NOD mice\, advancing specific immunotherapy for T1D. P
 lease join us!<br /></p><p><strong>Speaker:</strong><br />Prashanth Franci
 s\, MD PhD\, Assistant Professor\, Division of Gastroenterology and Hepato
 logy\, CU Anschutz\; Translational Research\, Gates Institute<strong></str
 ong></p>
END:VEVENT
END:VCALENDAR